The MicroByte Series-Streptococcus salivarius: The Oral Cavity Pioneer

Jul 16, 2025

•

6 min read

•

First identified in 1906, Streptococcus salivarius is a versatile Gram-positive bacterium capable of supporting a wide array of human health functions. Driven by an advanced arsenal of antimicrobial compounds and adhesion factors, it effortlessly balances mucosal immunity, spreading rapidly through early pioneer oral colonization. Benefits range from minor dental issues like plaque accumulation to severe localized complications, including middle ear and streptococcal throat infections. Accurate identification leverages classic laboratory cultures and modern tools like strain-specific genomic profiling. While optimization typically requires targeted probiotic therapy for strains like K-12 and M18, robust safety relies heavily on microbiome management and vulnerability screening.

History and naming

The genus Streptococcus was first characterized in 1874 by Theodor Billroth, an Austrian surgeon, who found them occurring singly, in pairs, or in chains- “Streptos” and “kokkos” are the Greek words for ‘chain’ and ‘berries’ respectively. The species S. salivarius was described in 1906 by Andrewes and Horder as follows: “There is a form of streptococcus so characteristic of saliva, though it is also common in the intestine, that the term streptococcus salivarius may justly be applied to it.” More than a hundred years later, this statement remains true, as it has not been renamed since.

Species- A specific group of closely related living organisms that share distinct common features and a high degree of genetic similarity.

Intestine- The long, tube-like section of the digestive system below the stomach that absorbs vital nutrients and water from food while processing the remaining waste.

Habitat

Streptococcus salivarius is a primarily human-associated microbe. It is an early resident of the oral cavity and is also found in the airways. It is also a prominent member of the gut microbiome, and it has been isolated from various parts of the gastrointestinal tract.

Oral cavity- The technical medical term for the inside of the mouth, which includes the lips, tongue, teeth, gums, and delicate inner cheek lining.

Gastrointestinal tract- The continuous human digestive system (or GI tract), stretching from the mouth down to the rectum, is responsible for breaking down food and housing a massive microbial ecosystem.

Health Benefits

S. salivarius plays an important role as a ‘pioneer’ species in the oral cavity, establishing itself on the first day of life. While it remains in the oral cavity even in adulthood, the dominance of this species from day 1 declines steadily even before the milk teeth erupt. In the oral cavity, too, S. salivarius has specific zones where it is found, being the dorsal surface of the tongue, due to its ability to adhere to epithelial surfaces, and the saliva. Here, it mounts a defence against incoming harmful oral bacteria like S. mutans and S. sobrinus in tooth sites, and has even been shown to block Aggregatibacter actinomycetemcomitans, a periodontal pathogen, from colonising epithelial cells. Strains of S. salivarius recovered from fecal samples have also been found to produce antimicrobial compounds, adding to the evidence of the role this microbe plays in maintaining multiple bodily ecosystems.

Epithelial surfaces- The protective cellular layers that coat the outside of the body (like the skin) and line the interior walls of internal passages (like the mouth and gut).

Periodontal pathogen- A dangerous, disease-causing microscopic organism that specifically attacks, infects, and damages the gums and bone structures supporting the teeth.

Strains- Specific genetic sub-types or unique variants within a single bacterial species, with each strain often displaying its own distinct functional traits or health perks.

Antimicrobial compounds- Protective substances manufactured by cells or friendly microbes that directly weaken, stop the growth of, or destroy competing, harmful germs.

Applications

Streptococcus salivarius has a wide range of applications as a probiotic, the K-12 and M18 strains being the most popular, are safe, orally derived, and have their own unique antimicrobial profiles. Foremost is S. salivarius’s use in relation to oral health, as it is a key member of the oral microflora. S. salivarius has been shown to improve various aspects of oral and dental health in children, such as reduction of black spot formation, caries prevention, inhibition of caries-causing S. mutans, and lessening of plaque scores. There is also evidence to show this microbe’s effectiveness in improving and preventing the occurrence of middle ear infection, a common infection in children.

Interestingly, it has been shown that supplementation with S. salivarius may even improve throat infections caused by Group A beta-hemolytic Streptococcus (GABHS). While ‘gold-standard’ trials for this are not indicative of this protective effect, other studies have shown significant improvements in the rate of illness in both adults and children. Further research is needed to establish S. salivarius’s utility in this aspect.

Probiotic- Live, beneficial microorganisms (often called "good bacteria") that provide documented health advantages when consumed or applied in proper amounts.

Caries prevention- The proactive medical or dental process of stopping tooth decay and cavity formation before they can break down tooth enamel.

Plaque- A sticky, colorless film of bacteria, saliva, and food particles that constantly forms on teeth, which can cause cavities and gum disease if not brushed away.

Group A beta-hemolytic Streptococcus (GABHS)- A specific strain of highly contagious, dangerous bacteria best known for causing painful infections like strep throat and scarlet fever.

Risks

Despite S. salivarius’ prominence in multiple human microbiomes and its probiotic potential, it exhibits mild virulence and has been implicated in multiple cases of localised or system-wide infections. In patients with compromised immune systems, it has been known to infect the bloodstream and cause complications in brain and spinal cord surgeries due to contamination. But these complications are situation-specific and rare. For healthy humans, this strain has a good safety profile for oral consumption.

Virulence- The specific degree of severity, aggressiveness, or destructive power a harmful microbe possesses to overcome defenses and cause disease inside a host.

Compromised immune systems- A vulnerable state where the body's natural defense network is severely weakened, making it much harder to fight off everyday infections and illnesses.

Fun fact

The widely used probiotic strain S. salivarius K12 was isolated first from a healthy schoolchild, who had no S. pyogenes infections for over a year. It was later confirmed to produce molecules that inhibit S. pyogenes, a common cause of bacterial throat infections. It also binds to human epithelial cells, providing colonisation competition to S. pyogenes. In fact, in further studies, it was shown that participants with greater S. salivarius levels experienced fewer streptococcal throat infections. So your oral microbiome may be protecting you against sore throats!

Microbe profile

Shape: Spherical-ovoid, chains or pairs

Gram nature: +ve

Spore formation: No

Biofilm formation: Yes

Oxygen requirement: facultative anaerobe

Optimal temperature: 37°C

Optimal pH: 6.7

Nutrient usage: Maltose, Glucose, Sucrose, Lactose

Taxonomic Classification

Kingdom: Bacteria

Phylum: Bacillota

Class: Bacilli

Order:Lactobacillales

Family: Streptococcaceae

Genus: Streptococcus

Species: Streptococcus salivarius

-Antara Arvind

Reference

Andrewes, F., & Horder, T. (1906). A STUDY OF THE STREPTOCOCCI PATHOGENIC FOR MAN. The Lancet, 168(4333), 708–713. https://doi.org/10.1016/s0140-6736(01)31538-6

Burton, J. P., Wescombe, P. A., Moore, C. J., Chilcott, C. N., & Tagg, J. R. (2006). Safety Assessment of the Oral Cavity Probiotic Streptococcus salivarius K12. Applied and Environmental Microbiology, 72(4), 3050–3053. https://doi.org/10.1128/aem.72.4.3050-3053.2006

Carlsson, J., Grahnén, H., & Jonsson, G. (1975). Lactobacilli and streptococci in the mouth of children. Caries Research, 9(5), 333–339. https://doi.org/10.1159/000260166

Couvigny, B., Kulakauskas, S., Pons, N., Quinquis, B., Abraham, A., Meylheuc, T., Delorme, C., Renault, P., Briandet, R., Lapaque, N., & Guédon, E. (2018). Identification of New Factors Modulating Adhesion Abilities of the Pioneer Commensal Bacterium Streptococcus salivarius. Frontiers in Microbiology, 9. https://doi.org/10.3389/fmicb.2018.00273

Etymologia: Streptococcus. (2016). Emerging Infectious Diseases, 22(11), 1977. https://doi.org/10.3201/eid2211.et2211

Gobbetti, M., & Calasso, M. (2014a). STREPTOCOCCUS | Introduction. In Elsevier eBooks (pp. 535–553). https://doi.org/10.1016/b978-0-12-384730-0.00324-4

Hossain, Z. (2014). Bacteria: streptococcus. In Elsevier eBooks (pp. 535–545). https://doi.org/10.1016/b978-0-12-378612-8.00116-5

Mallikarjun, S. B., Salim, H. P., Raju, S., & Surendranath, A. R. (2023). Randomized Clinical Trial of Oral Probiotic Streptococcus salivarius M18 on Salivary Streptococcus mutans in Preprimary Children. International Journal of Clinical Pediatric Dentistry, 16(2), 259–263. https://doi.org/10.5005/jp-journals-10005-2527

Patterson, M. J. (1996). Streptococcus. Medical Microbiology - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK7611/

Roger, P., Delettre, J., Bouix, M., & Béal, C. (2011). Characterization of Streptococcus salivarius growth and maintenance in artificial saliva. Journal of Applied Microbiology, 111(3), 631–641. https://doi.org/10.1111/j.1365-2672.2011.05077.x

Safford, C. E., Sherman, J. M., & Hodge, H. M. (1937). Streptococcus salivarius. Journal of Bacteriology, 33(3), 263–274. https://doi.org/10.1128/jb.33.3.263-274.1937

Sanketh, D., & Amrutha, N. (2013). Oral microbial flora in health. World Journal of Dentistry, 4(4), 262–266. https://doi.org/10.5005/jp-journals-10015-1242

Sun, M., Li, Q., Zhang, F., Yao, D., Huang, W., Lv, Q., Jiang, H., Kong, D., Ren, Y., Chen, S., Jiang, Y., & Liu, P. (2025). The Genomic Characteristics of Potential Probiotics: Two Streptococcus salivarius Isolates from a Healthy Individual in China. Microorganisms, 13(3), 694. https://doi.org/10.3390/microorganisms13030694

Wescombe, P. A., Hale, J. D., Heng, N. C., & Tagg, J. R. (2016, November 21). Developing Oral Probiotics From Streptococcus salivarius. Medscape. https://www.medscape.com/viewarticle/777316_4

Wilcox, C., Stuart, B., Leaver, H., Lown, M., Willcox, M., Moore, M., & Little, P. (2019). Effectiveness of the probiotic Streptococcus salivarius K12 for the treatment and/or prevention of sore throat: a systematic review. Clinical Microbiology and Infection, 25(6), 673–680. https://doi.org/10.1016/j.cmi.2018.12.031

Zupancic, K., Kriksic, V., Kovacevic, I., & Kovacevic, D. (2017). Influence of Oral Probiotic Streptococcus salivarius K12 on Ear and Oral Cavity Health in Humans: Systematic Review. Probiotics and Antimicrobial Proteins, 9(2), 102–110. https://doi.org/10.1007/s12602-017-9261-2

Al-Akel, F. C., Chiperi, L. E., Eszter, V. K., & Bacârea, A. (2024). Streptococcus salivarius Role as a Probiotic in Children’s Health and Disease Prophylaxis—A Systematic Review. Life, 14(12), 1613. https://doi.org/10.3390/life14121613

STREPTOCOCCUS SALIVARIUS

PROBIOTICS

Frequently Asked Questions

Why is Streptococcus salivarius considered a "pioneer" species in the human body?

It establishes itself in the oral cavity on the very first day of human life, long before milk teeth even begin to erupt. While its initial dominance naturally declines with age, it remains a lifelong protector residing on the tongue and inside saliva.

How do probiotic strains like K-12 and M18 actively improve dental health in children?

These specialized strains effectively lower plaque scores, prevent cavities, and reduce the formation of dark black spots on teeth. They achieve this by producing targeted antimicrobial profiles that directly block cavity-causing bacteria like Streptococcus mutans.

What did researchers discover about the origin and function of the popular probiotic strain K12?

It was originally isolated from a healthy schoolchild who naturally resisted painful strep throat infections for over an entire year. The strain works by physically binding to human epithelial cells and producing molecules that actively inhibit throat pathogens.

Can supplementing with Streptococcus salivarius help prevent illnesses outside of the mouth?

Yes, clinical evidence demonstrates that supplementation can significantly lessen the occurrence of common middle ear infections in young children. It also helps defend the upper respiratory tract against highly contagious throat infections caused by Group A Streptococcus.

Under what rare medical circumstances can Streptococcus salivarius pose a health risk?

While perfectly safe for healthy people, this microbe exhibits mild virulence that can threaten patients with compromised immune systems. In these rare cases, it can enter the bloodstream or cause complications during delicate brain and spinal surgeries.

BugSpeaks®

BugSpeaks®, developed by Leucine Rich Bio Pvt Ltd, South Asia’s first microbiome company, is headquartered in Bengaluru, India. Since 2014, the company has pioneered advanced analytics to analyze complex genomics data. Collaborating with leading research institutes globally, Leucine Rich Bio has leveraged its expertise to create BugSpeaks®, South Asia’s first gut microbiome test.

Visit Site